← Back to Search

tDCS for Cognitive Enhancement in Healthy Subjects (Normal_tDCS Trial)

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate (less than 60 minutes)

Summary

This trial is testing the effects of tDCS on cognition in healthy volunteers.

Who is the study for?
This trial is for healthy volunteers without any history of neurological or psychiatric diseases, abnormal MRI results, metal implants, pacemakers, severe hypertension, cardiovascular disease or family history of epilepsy. Pregnant or breastfeeding women are also excluded.
What is being tested?
The study tests the effects of transcranial direct current stimulation (tDCS) on brain function. Participants will undergo neuropsychological tests and brain imaging while receiving either real tDCS to left or right prefrontal cortex or sham (fake) tDCS.
What are the potential side effects?
Potential side effects from tDCS may include mild discomfort at the stimulation site, itching, tingling sensation during application, headache after treatment and fatigue.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate (less than 60 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate (less than 60 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
functional connectivity
Secondary study objectives
Stroop task performance

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Real Left DLPFC tDCSActive Control1 Intervention
Real tDCS on the left dorsolateral prefrontal cortex
Group II: Real Right DLPFC tDCSActive Control1 Intervention
Real tDCS on the right dorsolateral prefrontal cortex
Group III: Sham tDCSPlacebo Group1 Intervention
30sec ramp-up and 30sec ramp-down

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
619 Previous Clinical Trials
206,681 Total Patients Enrolled

Media Library

Real Left DLPFC tDCS Clinical Trial Eligibility Overview. Trial Name: NCT03027869 — N/A
Healthy Subjects Research Study Groups: Sham tDCS, Real Left DLPFC tDCS, Real Right DLPFC tDCS
Healthy Subjects Clinical Trial 2023: Real Left DLPFC tDCS Highlights & Side Effects. Trial Name: NCT03027869 — N/A
Real Left DLPFC tDCS 2023 Treatment Timeline for Medical Study. Trial Name: NCT03027869 — N/A
~5 spots leftby Nov 2025